As previously reported, BofA downgraded Navient (NAVI) to Underperform from Neutral with a price target of $12, down from $15. While the firm appreciates the company’s execution on cost cutting and business divestments, it views the “Phase 2” growth initiatives as more difficult than the “Phase 1” focus on expense reductions and capital allocation and believes a shift to growth has “significantly higher execution risk,” the analyst tells investors. Early indications suggest additional loan products, fee-based products, or leaning further into in-school lending are potential options, but all of these come with near-term risks, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NAVI:
- Navient downgraded to Underperform from Neutral at BofA
- Navient price target lowered to $12 from $13.50 at TD Cowen
- Navient price target lowered to $15 from $16.50 at Keefe Bruyette
- Navient Reports Mixed Q2 2025 Financial Results
- Navient’s Financial Challenges and Strategic Uncertainties Justify Sell Rating
